Flower - Wikipedia
WEBA flower, also known as a bloom or blossom, is the reproductive structure found in flowering plants (plants of the division Angiospermae). Flowers consist of a combination of vegetative organs – sepals that enclose and protect the developing flower.
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With ...
WEBJun 3, 2024 · The study demonstrates significant intracranial efficacy and survival benefits of 80 mg once daily osimertinib in NSCLC patients with LMs. The data support considering daily 80 mg of osimertinib as a treatment option for EGFR-mutated NSCLC patients with LMs, irrespective of T790M mutation status.
Program Guide – ASCO Meeting Program Guide - American …
WEBA phase II, open-label, single-arm, multicenter, efficacy and safety study of 80 mg osimertinib in patients with leptomeningeal metastases (LM) associated with epidermal growth factor receptor (EGFR) mutation–positive …
WEBA phase II, open-label, single-arm, multicenter, efficacy and safety study of 80 mg osimertinib in patients with leptomeningeal metastases (LM) associated with epidermal growth factor receptor (EGFR) mutation positive …
Protective skin aging effects of cherry blossom extract
WEBMar 15, 2019 · Extracts of the cherry blossom plant have been reported to exert various biological effects on human cells. However, no previous investigations have examined the antioxidant and anti-apoptotic effects of these extracts on ultraviolet B (UVB) radiation-induced skin aging.
Protective skin aging effects of cherry blossom extract (Prunus ...
WEBThis study explores the underlying mechanisms of the antioxidant and anti-apoptotic effects of cherry blossom extract (CBE) in human keratinocyte (HaCaT) cells. HaCaT cells were treated with CBE at concentrations of 0.5, 1.0, and 2.0% for 24 h and then irradiated with UVB (40 mJ/cm 2).
Osimertinib in Patients With Epidermal Growth Factor Receptor ... - PubMed
WEBFeb 20, 2020 · Purpose: In this phase I study (BLOOM), osimertinib, a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI), was evaluated in patients with leptomeningeal metastases (LMs) from EGFR-mutated (EGFRm) advanced non-small-cell lung cancer (NSCLC) whose disease …
Blossom-end rot: a century-old problem in tomato
WEBJan 12, 2022 · Blossom-end rot (BER) is a devastating physiological disorder affecting vegetable production worldwide. Extensive research into the physiological aspects of the disorder has demonstrated that the underlying causes of BER are associated with perturbed calcium (Ca2+) homeostasis and irregular watering conditions in predominantly cultivated ...
Anti-aging effect of Guanshan cherry blossom extract by …
WEBOct 1, 2023 · Studies have been conducted using cherry blossom extract to inhibit the trans-activation of AP-1 through inhibition of the MEK1/1-ERK pathway, thereby suppressing sUV-induced MMP-2 expression and thereby improving skin health (Jung, Lee, Lee, Shin, & …
Protective skin aging effects of cherry blossom extract
WEBMar 15, 2019 · This study explores the underlying mechanisms of the antioxidant and anti-apoptotic effects of cherry blossom extract (CBE) in human keratinocyte (HaCaT) cells. HaCaT cells were treated with CBE at concentrations of 0.5, 1.0, and 2.0% for 24 h and then irradiated with UVB (40 mJ/cm2).
- Some results have been removed